Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
Levels of two proteins in a woman’s ovarian cancer are strongly associated with her likelihood of survival, a research team led by scientists at The University of Texas…
NEW YORK (Reuters Health) – The presence and severity of mental illness are associated with an increased risk of asthma, according to study findings in the December issue…
NEW YORK (Reuters Health) – Among patients undergoing cardiac surgery with cardiopulmonary bypass, tight perioperative control of blood glucose levels is linked to a lower risk of, and…
NEW YORK (Reuters Health) – Long-term exposure to anticholinergic agents is associated with poor memory and executive function in older men, according to a report in the Journal…
NEW YORK (Reuters Health) – The incidence of non-Hodgkin’s lymphoma (NHL) is increased somewhat in patients with diabetes, according to results of a meta-analysis published in Diabetes Care…
NEW YORK (Reuters Health) – The results of a case-control study suggest that the benefit of colonoscopy in preventing colorectal cancer deaths is largely limited to left-sided malignancies.…
NEW YORK (Reuters Health) – Patients who are undernourished after experiencing an acute stroke benefit from intensive protein and energy supplementation during inpatient rehabilitation, according to results of…
NEW YORK (Reuters Health) – Intensive treatment to lower low-density lipoprotein cholesterol (LDL-C) reduces carotid intima-media thickness (CIMT) in patients with type 2 diabetes, according to a secondary…
NEW YORK (Reuters Health) – Results of a phase I trial suggest that intralesional transfer of plasmid interleukin (IL)-12 enhanced by electroporation for treatment of metastatic melanoma is…
NEW YORK (Reuters Health) – A 2.5-mg dose of terbutaline at bedtime appears to prevent hypoglycemia during the night in patients with aggressively treated type 1 diabetes, without…
